A study of the combination of oxaliplatin, capecitabine, and trastuzumab and chemo-radiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastroesophageal junction cancer (TOXAG study). için istatistikler

Toplam ziyaret

views
A study of the combination of oxaliplatin, capecitabine, and trastuzumab and chemo-radiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastroesophageal junction cancer (TOXAG study). 0

Aylık toplam ziyaret

views
Ocak 2024 0
Şubat 2024 0
Mart 2024 0
Nisan 2024 0
Mayıs 2024 0
Haziran 2024 0
Temmuz 2024 0